PYSZCZYMUKA GREG
SEC insider (Form 3/4/5 filer). CIK 0001952920. Chief Commercial Officer at AYTU BIOPHARMA, INC (AYTU) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DENVER, CO.
Companies PYSZCZYMUKA GREG has filed insider reports for
- AYTU BIOPHARMA, INC (AYTU): Officer, Chief Commercial Officer
- Evoke Pharma Inc (EVOK): Director
PYSZCZYMUKA GREG
CIK: 0001952920
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 28, 2026AYTU
AYTU BIOPHARMA, INC
AwardDirect20K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
5.8K shares- - Dec 17, 2025EVOK
Evoke Pharma Inc
DispositionDirectStock Option (Right to Buy)
1.2K shares- - Oct 3, 2025AYTU
AYTU BIOPHARMA, INC
AwardDirect12.5K shares- - May 21, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
1.2K shares- - Mar 31, 2025AYTU
AYTU BIOPHARMA, INC
ExerciseDirect209 shares- - Feb 20, 2025EVOK
Evoke Pharma Inc
AwardDirectStock Option (Right to Buy)
5.8K shares- - Dec 31, 2024AYTU
AYTU BIOPHARMA, INC
ExerciseDirect208 shares- - Nov 6, 2024AYTU
AYTU BIOPHARMA, INC
AwardDirectEmployee Stock Option (Right to Buy)
7K shares- - Sep 30, 2024AYTU
AYTU BIOPHARMA, INC
ExerciseDirect209 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  AYTU AYTU BIOPHARMA, INC | Award | 20,000 | - | $0 | Direct |
| Dec 17, 2025 |  EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 5,833 | - | - | Direct |
| Dec 17, 2025 | EVOK Evoke Pharma Inc | Disposition Stock Option (Right to Buy) | 1,155 | - | - | Direct |
| Oct 3, 2025 | AYTU AYTU BIOPHARMA, INC | Award | 12,500 | - | - | Direct |
| May 21, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 1,155 | - | - | Direct |
| Mar 31, 2025 | AYTU AYTU BIOPHARMA, INC | Exercise | 209 | - | - | Direct |
| Feb 20, 2025 | EVOK Evoke Pharma Inc | Award Stock Option (Right to Buy) | 5,833 | - | - | Direct |
| Dec 31, 2024 | AYTU AYTU BIOPHARMA, INC | Exercise | 208 | - | $0 | Direct |
| Nov 6, 2024 | AYTU AYTU BIOPHARMA, INC | Award Employee Stock Option (Right to Buy) | 7,000 | - | - | Direct |
| Sep 30, 2024 | AYTU AYTU BIOPHARMA, INC | Exercise | 209 | - | $0 | Direct |
1-10 of 10 transactions